Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Blackhawk Growth Corp C.BLR

Alternate Symbol(s):  C.BLR.WT | BLRZF

Blackhawk Growth Corp. is a Canada-based investment holding company. The Company invests in equity and debt instruments of companies to generate positive returns for shareholders. It focuses on investing in multiple companies across a variety of sectors across North America. The Company has focused its investments on the health, cannabis and cannabidiol (CBD) industries, in both Canada and the... see more

CSE:BLR - Post Discussion

Blackhawk Growth Corp > BLR CEO and Mindbio Will Lead Investor Presentation Feb. 2nd
View:
Post by bveilleu on Feb 01, 2022 9:08am

BLR CEO and Mindbio Will Lead Investor Presentation Feb. 2nd

Vancouver, British Columbia - TheNewswire - February 1, 2021 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the “Company” or “Blackhawk”) is pleased to announce that its CEO Frederick Pels, along with MindBio Therapeutics co-founder, Justin Hanka, will conduct an investor presentation and question and answer session on Wednesday, Feburary 2nd at 3pm PST.

 

Details of the investor presentation are as follows:

 

Join Meeting

https://us02web.zoom.us/j/87883517427

 

Meeting ID: 878 8351 7427

 

The presentation will be recorded and published on the MindBio https://mindbiotherapeutics.com and Blackhawk website on conclusion of the presentation.

 

“This is a great opportunity for investors to meet Justin Hanka, and get a better understanding of MindBio and its value-add for our shareholders” said Frederick Pels, CEO of Blackhawk Growth Corp. “MindBio is shaping up to be one of the leading drug development companies focused on mental health. With a Phase 1 clinical trial near successful completion plus a fully funded Phase 2 clinical trial, and a further two clinical trials starting in 2022, MindBio is fast becoming a leader in psychedelic medicines.”

 

Investors are encouraged to e-mail their questions beforehand to Frederick Pels at fred@blackhawkgrowth.com

 

About Blackhawk Growth

 

Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies. It has focused its investments in the health, cannabis and cannabidiol industries in both Canada and the United States. Its portfolio of companies includes TERP Wholesale, Sac Pharma, LeichtMind Clinics, Noble Hemp, Spaced Food, NuWave Foods, MindBio Therapeutics and Digital Mind Technology, as well as an equity position in Gaia Grow (CSE:GAIA).

The Company diligently posts updates through videos from the official company YouTube channel https://www.youtube.com/channel/UCs4f2tt3yAvOGhNLjgNOy-A  

Please join the conversation on our Blackhawk group supporter’s telegram group at https://t.me/Blackhawkgrowthcorp and visit us online at https://www.blackhawkgrowth.com

For further information please contact:

Frederick Pels, Chief Executive Officer

(403)-991-7737

fred@blackhawkgrowth.com

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities